Structural and Thermodynamic Consequences of 1-(4-Chlorophenyl)imidazole Binding to Cytochrome P450 2B4,

Yonghong Zhao,§ Ling Sun,§ B. K. Muralidhara,§ Santosh Kumar,§ Mark A. White,# C. David Stout, and James R. Halpert*§
Department of Pharmacology and Toxicology, University of Texas Medical Branch, 301 University Boulevard, Galveston, Texas 77555-1031, Sealy Center for Structural Biology and Molecular Biophysics, University of Texas Medical Branch, 301 University Boulevard, Galveston, Texas 77555, and Department of Molecular Biology, The Scripps Research Institute, La Jolla, California 92037
Biochemistry, 2007, 46 (41), pp 11559–11567
DOI: 10.1021/bi7011614
Publication Date (Web): September 22, 2007
Copyright © 2007 American Chemical Society

 This work was supported by NIH Grants ES03619 (to J.R.H.), GM61545 (to C.D.S.), and Center Grant ES06676 (to J.R.H.). Y.Z. was supported by NIEHS Training Grant T32 ES07254. The Stanford Synchrotron Radiation Laboratory is operated by Stanford University on behalf of the United States Department of Energy, Office of Basic Energy Sciences. The Stanford Synchrotron Radiation Laboratory Structural Molecular Biology Program is supported by the Department of Energy, Office of Biological and Environmental Research, and by the National Center for Research Resources, Biomedical Technology Program, and the National Institute of General Medical Sciences, National Institutes of Health. The Sealy Center for Structural Biology and Molecular Biophysics is supported by the Sealy and Smith Foundation for Medical Research.

,

 Atomic coordinates have been deposited in the Protein Data Bank as entry 2Q6N.

,
§

 Department of Pharmacology and Toxicology, University of Texas Medical Branch.

,

 Present address:  Centocor Inc., 145 King of Prussia Road, Radnor, PA 19087.

,

 Present address:  Pfizer Inc., PhRD-Global Biologics, 700 Chesterfield Parkway West, Chesterfield, MO 63017.

,
#

 Sealy Center for Structural Biology and Molecular Biophysics, University of Texas Medical Branch.

,

 The Scripps Research Institute.

,
*

 Corresponding author. Tel:  (409) 772-9678. Fax:  (409) 772-5732. E-mail:  jhalpert@utmb.edu.

Abstract

Abstract Image

The crystal structure of P450 2B4 bound with 1-(4-chlorophenyl)imidazole (1-CPI) has been determined to delineate the structural basis for the observed differences in binding affinity and thermodynamics relative to 4-(4-chlorophenyl)imidazole (4-CPI). Compared with the previously reported 4-CPI complex, there is a shift in the 1-CPI complex of the protein backbone in helices F and I, repositioning the side chains of Phe-206, Phe-297, and Glu-301, and leading to significant reshaping of the active site. Phe-206 and Phe-297 exchange positions, with Phe-206 becoming a ligand-contact residue, while Glu-301, rather than hydrogen bonding to the ligand, flips away from the active site and interacts with His-172. As a result the active site volume expands from 200 Å3 in the 4-CPI complex to 280 Å3 in the 1-CPI complex. Based on the two structures, it was predicted that a Phe-206→Ala substitution would alter 1-CPI but not 4-CPI binding. Isothermal titration calorimetry experiments indicated that this substitution had no effect on the thermodynamic signature of 4-CPI binding to 2B4. In contrast, relative to wild-type 1-CPI binding to F206A showed significantly less favorable entropy but more favorable enthalpy. This result is consistent with loss of the aromatic side chain and possible ordering of water molecules, now able to interact with Glu-301 and exposed residues in the I-helix. Hence, thermodynamic measurements support the active site rearrangement observed in the crystal structure of the 1-CPI complex and illustrate the malleability of the active site with the fine-tuning of residue orientations and thermodynamic signatures.

Tools

Accession Codes

History

  • Published In Issue October 16, 2007
  • Received June 12, 2007
    Revised Manuscript Received July 30, 2007

Recommend & Share